Case Number 3596
Request Date 22/04/2014
Completion Date 22/04/2014


Details of the Request

In your organisation please supply the number of patients currently being treated with biologics, for the following conditions, please split by named biologic and condition where possible. If you are unable to provide the number of current patients could you provide the number of patients treated in the last 6 months;

  • Rheumatoid Arthritis
  • Ankylosing Spondylitis (if split by individual Arthropathy is not possible, please state total for Spondyloarthropathies)
  • Non-radiographic axial Spondyloarthritis
  • Psoriatic Arthritis
  • Psoriasis
  • Crohn's disease
  • Ulcerative Colitis

Total Patients and where possible split by Biologic;


If possible, please supply the data using the following;

  • Number of patients currently being treated
  • Abatacept
  • Adalimumab
  • Anakinra
  • Certolizumab
  • Etanercept
  • Golimumab
  • Infliximab
  • Rituximab
  • Tocilizumab
  • Tofacitinib
  • Ustekinumab
  • Others


Details of the Response

Please see attached table.

The Infliximab for Ulcerative Colitis and Rituximab for Rheumatoid Arthritis are short duration courses so the Trust has provided the number of patients approved funding in the last 6 months. The other treatments are on-going so the numbers represent the current on-going treatment numbers.